Thermo Fisher Scientific Stock

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-22 pm EDT 5-day change 1st Jan Change
548.4 USD +0.66% Intraday chart for Thermo Fisher Scientific -1.70% +3.31%
Sales 2024 * 43B Sales 2025 * 46.02B Capitalization 209B
Net income 2024 * 6.34B Net income 2025 * 7.06B EV / Sales 2024 * 5.39 x
Net Debt 2024 * 22.52B Net Debt 2025 * 17.76B EV / Sales 2025 * 4.93 x
P/E ratio 2024 *
33.3 x
P/E ratio 2025 *
28.9 x
Employees 122,000
Yield 2024 *
0.27%
Yield 2025 *
0.29%
Free-Float 87.14%
More Fundamentals * Assessed data
Dynamic Chart
Bernstein Adjusts Price Target on Thermo Fisher Scientific to $544 From $520, Market Perform Rating Kept MT
Baird Adjusts Price Target on Thermo Fisher Scientific to $621 From $597 MT
TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612 MT
HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630 MT
Thermo Fisher Scientific Inc. Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing CI
Thermo Fisher Scientific Receives Shareholder Proposal from John Chevedden CI
Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets CI
RBC Raises Price Target on Thermo Fisher Scientific to $657 From $642, Keeps Outperform Rating MT
Thermo Fisher Scientific Introduces Its Newest Line of High Performance, Ultra-Low Temperature Freezers CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period MT
South Korean Trade Ministry, Thermo Fisher Scientific Explore Potential for Raw Biomaterials Facility MT
Thermo Fisher Scientific Announces A New In-Line Metrology Solution to Improve Battery Safety and Performance CI
Olink Swings to Q4 Net Loss, Revenue Rises MT
Bayer AG and Thermo Fisher Scientific Inc. Collaborate to Increase Patient Access to Precision Cancer Medicines CI
Thermo Fisher Scientific Insider Sold Shares Worth $5,945,759, According to a Recent SEC Filing MT
More news
1 day+0.66%
1 week-1.70%
Current month-5.65%
1 month-5.95%
3 months-0.91%
6 months+18.75%
Current year+3.31%
More quotes
1 week
529.64
Extreme 529.64
559.04
1 month
529.64
Extreme 529.64
589.93
Current year
527.32
Extreme 527.32
603.82
1 year
415.60
Extreme 415.6
603.82
3 years
415.60
Extreme 415.6
672.34
5 years
250.21
Extreme 250.21
672.34
10 years
107.33
Extreme 107.33
672.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 55 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change Volume
24-04-22 548.4 +0.66% 1,520,409
24-04-19 544.8 +0.60% 1,738,509
24-04-18 541.5 -1.05% 2,075,785
24-04-17 547.2 -1.32% 1,610,057
24-04-16 554.6 -0.60% 1,010,299

Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
544.8 USD
Average target price
609.4 USD
Spread / Average Target
+11.86%
Consensus